Relmada Therapeutics (RLMD) Debt Ratio (2014 - 2019)

Relmada Therapeutics (RLMD) has reported Debt Ratio for 6 consecutive years, with 0.0 the latest figure, recorded in Q4 2019.

• In Q4 2019, Debt Ratio fell 97.29% year-over-year to 0.0; the TTM figure through Dec 2019 stood at 0.0 (down 97.29% YoY), while the FY2019 annual figure was 0.0, changed N/A from the prior year.
• Debt Ratio eased to 0.0 in Q4 2019 per RLMD's latest filing, from 0.03 in the prior quarter.
• Across five years, Debt Ratio topped out at 2.05 in Q3 2018 and bottomed at 0.0 in Q4 2019.
• Historically, Debt Ratio has averaged 0.15 across 5 years, with a median of 0.02 in 2016.
• Annual changes were most pronounced in 2018 — Debt Ratio soared 1596.81% — and 2019, when it plunged 98.54%.
• Relmada Therapeutics' Debt Ratio stood at 0.01 in 2015, then surged by 231.52% to 0.02 in 2016, then soared by 999.98% to 0.19 in 2017, then plunged by 82.11% to 0.03 in 2018, then tumbled by 97.29% to 0.0 in 2019.
• Business Quant data shows RLMD's Debt Ratio at 0.0 in Q4 2019, 0.03 in Q3 2019, and 0.04 in Q2 2019.